Metabolic Effects of Second Generation Antipsychotics in Youth: Subproject 3 Final Report

Project Title Metabolic Effects of Second Generation Antipsychotics in Youth: Subproject 3 Final Report
Description

Protocol-based one-time assessment to determine the average change in body mass index (BMI) z-score among youth initiating monotherapy treatment with olanzapine, quetiapine or risperidone compared to aripiprazole between baseline (treatment initiation) and: (i) 12 weeks (+/- 2 weeks), and (ii) 52 weeks (+/- 8 weeks) in the Mini-Sentinel Distributed Database (MSDD) population. 

Link
Published Date
Friday, February 2, 2018
Category
Final Results and Reports